Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.17
-0.4000-0.26%
Volume:415.28K
Turnover:65.29M
Market Cap:15.93B
PE:22.89
High:159.67
Open:157.96
Low:156.17
Close:156.57
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:0.60
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.31
PE(LYR):33.44

Loading ...

Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities